Calvarium indentations in multiple myeloma and CAR T-cell therapy

被引：0
|
作者：
Munoz, Javier [1 ]
Larsen, Jeremy [1 ]
机构：
[1] Mayo Clin, Haematol & Oncol, Phoenix, AZ 85054 USA
来源：
LANCET | 2022年 / 400卷 / 10349期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [21] CAR T-cell therapy: is it prime time in myeloma?
    Sidana, Surbhi
    Shah, Nina
    BLOOD ADVANCES, 2019, 3 (21) : 3473 - 3480
  • [22] CAR T-cell therapy: is it prime time in myeloma?
    Sidana, Surbhi
    Shah, Nina
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 260 - 265
  • [23] Updates on CAR T cell therapy in multiple myeloma
    Nasiri, Fatemeh
    Asaadi, Yasaman
    Mirzadeh, Farzaneh
    Abdolahi, Shahrokh
    Molaei, Sedigheh
    Gavgani, Somayeh Piri
    Rahbarizadeh, Fatemeh
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [24] CAR T-Cell Therapy Against B-Cell Maturation Antigen in Multiple Myeloma
    Cohen, Adam D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (12) : 804 - 806
  • [25] CAR T-cell therapy to treat multiple myeloma: current state and future directions
    Reddy, Siddhartha Thammineni
    Hosoya, Hitomi
    Mikkilineni, Lekha
    CANCER AND METASTASIS REVIEWS, 2025, 44 (01)
  • [26] Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper
    Gagelmann, Nico
    Sureda, Anna
    Montoto, Silvia
    Murray, John
    Bolanos, Natacha
    Kenyon, Michelle
    Beksac, Meral
    Schonland, Stefan
    Hayden, Patrick
    Scheurer, Hans
    Morgan, Kate
    Garderet, Laurent
    McLornan, Donal P.
    Ruggeri, Annalisa
    LANCET HAEMATOLOGY, 2022, 9 (10): : E786 - E795
  • [27] Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy
    Pan, Darren Denjay
    Mouhieddine, Tarek H.
    Fu, Weijia
    Moshier, Erin
    Parekh, Samir
    Jagannath, Sundar
    Rossi, Adriana C.
    Cho, Hearn Jay
    Richter, Joshua
    Sanchez, Larysa J.
    Thibaud, Santiago
    Rodriguez, Cesar
    Richard, Shambavi
    BLOOD, 2023, 142
  • [28] CAR T-Cell Therapy for Multiple Myeloma: A Clinical Practice-Oriented Review
    Sadek, Norah Layla
    Costa, Bruno Almeida
    Nath, Karthik
    Mailankody, Sham
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1184 - 1195
  • [29] CD4+CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy
    Ledergor, Guy
    Fan, Zenghua
    Wu, Kai
    Mccarthy, Elizabeth
    Hyrenius-Wittsten, Axel
    Starzinski, Alec
    Chang, Hewitt
    Bridge, Mark
    Kwek, Serena
    Cheung, Alexander
    Bylsma, Sophia
    Hansen, Erik
    Wolf, Jeffrey
    Wong, Sandy
    Shah, Nina
    Roybal, Kole T.
    Martin, Thomas
    Ye, Chun J.
    Fong, Lawrence
    BLOOD ADVANCES, 2024, 8 (13) : 3562 - 3575
  • [30] European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
    Bruno, Benedetto
    Wasch, Ralph
    Engelhardt, Monika
    Gay, Francesca
    Giaccone, Luisa
    D'Agostino, Mattia
    Rodriguez-Lobato, Luis-Gerardo
    Danhof, Sophia
    Gagelmann, Nico
    Kroeger, Nicolaus
    Popat, Rakesh
    van de Donk, Niels W. C. J.
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Sonneveld, Pieter
    Einsele, Hermann
    Boccadoro, Mario
    HAEMATOLOGICA, 2021, 106 (08) : 2054 - 2065
12345